XELODA 150 (Xeloda 150 mg)
Generic Name: capecitabine
Pill imprint XELODA 150 has been identified as Xeloda 150 mg.
Xeloda is used in the treatment of colorectal cancer; breast cancer, metastatic; pancreatic cancer; breast cancer; stomach cancer (and more), and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Xeloda 150 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for XELODA 150
- Generic Name:
- 150 mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Roche Laboratories
- National Drug Code (NDC):
- Inactive Ingredients:
- croscarmellose sodium
hypromellose 2208 (15000 mPa.s)
ferric oxide red
ferric oxide yellow
|NDC Code||Manufacturer / Repackager|
|54868-4143||Physicians Total Care Inc (repackager)|
Note: Inactive ingredients may vary.
More about Xeloda (capecitabine)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.